Elective and Emergency Deep Brain Stimulation in Refractory Pediatric Monogenetic Movement Disorders Presenting with Dystonia: Current Practice Illustrated by Two Cases: Current Practice illustrated by Two Cases

L.A. van de Pol, Martinica Garofalo, Martijn Beudel, Joke M. Dijk, Laura A. Bonouvrié, Annemieke I. Buizer, Joke Geytenbeek, Rosanne H. N. Prins, P. Rick Schuurman

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)

Abstract

Background Dystonia is characterized by sustained or intermittent muscle contractions, leading to abnormal posturing and twisting movements. In pediatric patients, dystonia often negatively influences quality of life. Pharmacological treatment for dystonia is often inadequate and causes adverse effects. Deep brain stimulation (DBS) appears to be a valid therapeutic option for pharmacoresistant dystonia in children. Methods To illustrate the current clinical practice, we hereby describe two pediatric cases of monogenetic movement disorders presenting with dystonia and treated with DBS. We provide a literature review of similar previously described cases and on different clinical aspects of DBS in pediatric dystonia. Results The first patient, a 6-year-old girl with severe dystonia, chorea, and myoclonus due to an ADCY5 gene mutation, received DBS in an elective setting. The second patient, an 8-year-old boy with GNAO1-related dystonia and chorea, underwent emergency DBS due to a pharmacoresistant status dystonicus. A significant amelioration of motor symptoms (65% on the Burke-Fahn-Marsden Dystonia Rating Scale) was observed postoperatively in the first patient and her personal therapeutic goals were achieved. DBS was previously reported in five patients with ADCY5-related movement disorders, of which three showed objective improvement. Emergency DBS in our second patient resulted in the successful termination of his GNAO1-related status dystonicus, this being the eighth case reported in the literature. Conclusion DBS can be effective in monogenetic pediatric dystonia and should be considered early in the disease course. To better evaluate the effects of DBS on patients' functioning, patient-centered therapeutic goals should be discussed in a multidisciplinary approach.

Original languageEnglish
Pages (from-to)44-52
Number of pages9
JournalNeuropediatrics
Volume54
Issue number1
Early online date12 Oct 2022
DOIs
Publication statusPublished - Feb 2023

Keywords

  • ADCY5 gene
  • GNAO1 gene
  • deep brain stimulation
  • monogenetic movement disorders
  • pediatric dystonia
  • status dystonicus

Cite this